Rani makes it rain with $53m · Articles · Global Corporate Venturing
Venture Houston 2018
Skip Content

12 February 2018

Rani makes it rain with $53m

Rani Therapeutics has now raised $142m in total, its latest investors including GV, Ping An Ventures, GeneScience, AstraZeneca, Shire and Novartis.

Author: Robert Lavine, News Editor

Rani Therapeutics, a US-based developer of oral treatments for chronic diseases, has received $53m in funding from internet technology group Alphabet, insurance firm Ping An and several pharmaceutical companies.